Medication for Opioid Use Disorder and Perioperative Outcomes for Benign Hysterectomy
Among patients with OUD undergoing hysterectomy, MOUD use was associated with reduced perioperative complications and health care utilization. Findings support methadone and buprenorphine use to improve hysterectomy surgical outcomes, particularly with more than 90 days of MOUD.
Authors
- June Y. Hou (ORCID: https://orcid.org/0000-0002-6022-0035)
- Sílvia S. Martins (ORCID: https://orcid.org/0000-0003-3059-9993)
- Pia M. Mauro (ORCID: https://orcid.org/0000-0003-2482-8841)
- Jason D. Wright (ORCID: https://orcid.org/0000-0001-6390-825X)
- G. Li
- Ang Li (ORCID: https://orcid.org/0000-0002-9023-0162)
- Adam Bisaga (ORCID: https://orcid.org/0000-0003-1415-5436)
- Dawn L Hershman
- Xiao Xu
- Yongmei Huang
Institutions
- Columbia University (US)
Publication Details
- Journal
- O&G Open
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1097/og9.0000000000000146
- Primary Topic
- Uterine Myomas and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company